Cipla celebrates 90 years with focus on quality products, global presence, and investment in research and technology.

A significant reduction was not observed in the annualised rate of moderate or severe COPD exacerbations with tezepelumab versus placebo. Further studies are required to evaluate the efficacy of ...

Though long-term prospects appear sound, near-term earnings visibility remains limited for Dr. Reddy's Labs, Cipla, and Lupin ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Linda Jónsdóttir as ...

Ivers-Lee was founded in Burgdorf, Switzerland in 1947, to supply innovative packaging services for the pharmaceutical sector. In addition to the site in Burgdorf, Ivers-Lee also operates a strategic ...

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the ...

Mumbai-headquartered drugmaker Cipla Ltd is bolstering its focus on a pipeline of drugs to fight infections caused by ...

Shanghai: Indian pharmaceutical giant Cipla is exploring entry into at least two new international markets for products ...

Indian drugmaker Cipla is looking to add at least two new overseas markets for its products manufactured in China, as the firm seeks to work around constrained production capacity in India, a ...

SHANGHAI (Reuters) -Indian drugmaker Cipla is looking to add at least two new overseas markets for its products manufactured in China, as the firm seeks to work around constrained production capacity ...